bufexamac and its Impurities

Bufexamac was withdrawn in Europe because of allergic reactions. It is a drug used as an anti-inflammatory agent on the skin, as well as rectally. Common brand names include Paraderm and Parfenac.. Reference standards of Bufexamac API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 14 results for bufexamac Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 02 55000

Bufexamac

Bufexamac


  • Catalogue No.:PA 02 55000

  • CAS :

    2438-72-4

  • Molecular Formula : C12H17NO3

  • Molecular Weight : 223.27

Drug Reference Standards & Impurity Synthesis in India
PA 02 55010

Bufexamac - Impurity A

2-(4-Butoxyphenyl)acetic Acid


  • Catalogue No.:PA 02 55010

  • CAS :

    4547-57-3

  • Molecular Formula : C12H16O3

  • Molecular Weight : 208.25

Drug Reference Standards & Impurity Synthesis in India
PA 02 55020

Bufexamac - Impurity B

Methyl 2-(4-Butoxyphenyl)-acetate


  • Catalogue No.:PA 02 55020

  • CAS :

    29056-06-2

  • Molecular Formula : C13H18O3

  • Molecular Weight : 222.28

Drug Reference Standards & Impurity Synthesis in India
PA 02 55030

Bufexamac - Impurity C

Butyl 2-(4-Butoxyphenyl)-acetate


  • Catalogue No.:PA 02 55030

  • CAS :

    1185726-73-1

  • Molecular Formula : C16H24O3

  • Molecular Weight : 264.36

Drug Reference Standards & Impurity Synthesis in India
PA 02 55040

Bufexamac - Impurity D

2-(4-Butoxyphenyl)acetamide


  • Catalogue No.:PA 02 55040

  • CAS :

    3413-59-0

  • Molecular Formula : C12H17NO2

  • Molecular Weight : 207.27

Drug Reference Standards & Impurity Synthesis in India
PA 02 55510

4'-Butoxyacetophenone

4'-Butoxyacetophenone


  • Catalogue No.:PA 02 55510

  • CAS :

    5739-89-0

  • Molecular Formula : C12H16O2

  • Molecular Weight : 192.25

Drug Reference Standards & Impurity Synthesis in India
PA 02 55520

Ethyl 2-(4-Butoxyphenyl)acetate

Ethyl 2-(4-Butoxyphenyl)acetate


  • Catalogue No.:PA 02 55520

  • CAS :

    4547-58-4

  • Molecular Formula : C14H20O3

  • Molecular Weight : 236.31

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001731

Bufexamac impurity C (Y0001731)

Bufexamac impurity C (Y0001731)


  • Catalogue No.:PA EPY0001731

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPB1156000

Bufexamac (B1156000)

Bufexamac (B1156000)


  • Catalogue No.:PA EPB1156000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001730

Bufexamac impurity B (Y0001730)

Bufexamac impurity B (Y0001730)


  • Catalogue No.:PA EPY0001730

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001732

Bufexamac impurity D (Y0001732)

Bufexamac impurity D (Y0001732)


  • Catalogue No.:PA EPY0001732

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001729

Bufexamac impurity A (Y0001729)

Bufexamac impurity A (Y0001729)


  • Catalogue No.:PA EPY0001729

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 02 0551000

2-(4-(2-Hydroxyethyl)phenyl)-2-methylpropanoic acid

2-(4-(2-Hydroxyethyl)phenyl)-2-methylpropanoic acid


  • Catalogue No.:PA 02 0551000

  • CAS :

    552301-45-8

  • Molecular Formula : C12H16O3

  • Molecular Weight : 208.26

Drug Reference Standards & Impurity Synthesis in India
PA 02 0551001

2-(4-(2-Hydroxyethyl)phenyl)-2-methylpropanoic acid, Sodium Salt

2-(4-(2-Hydroxyethyl)phenyl)-2-methylpropanoic acid, Sodium Salt


  • Catalogue No.:PA 02 0551001

  • CAS :

    2052955-70-9

  • Molecular Formula : C12H16NaO3

  • Molecular Weight : 231.25

pharmaffiliates